This report offers one of the most comprehensive insights into global trends in international culture, production, seizure and price of illicit drugs. It examines trends in the world's four major markets: opium and heroin, coca and cocaine, cannabis, and amphetamine-type stimulants. This edition provides an in-depth examination of the link between transnational organized crime and drug trafficking. A detailed statistical appendix on production, prices and consumption completes this book, which gives the reader a comprehensive picture of the world's drug problem.
The 2019 World Drug Report will include an updated overview of recent trends on production, trafficking and consumption of key illicit drugs. The Report contains a global overview of the baseline data and estimates on drug demand and supply and provides the reference point for information on the drug situation worldwide.
Drawing on the Household Living Arrangements of Older Persons 2019 Dataset, the World Population Ageing 2020 Highlights will document key patterns and trends of the household living arrangements of older persons around the world.
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
In this completely revised and updated third edition of his highly successful book, Hamid Ghodse presents a comprehensive overview of substance misuse and dependence. There is a particular emphasis on practical, evidence-based approaches to the assessment and management of a wide range of drug-related problems in a variety of clinical settings, and he has written an entirely new chapter on alcohol abuse. He defines all the terms, and describes the effects of substance misuse on a patient's life. Epidemiology, and international prevention and drug control policies are covered to address the global nature of the problem, and the appendix provides a series of clinical intervention tools, among them a Substance Misuse Assessment Questionnaire. This will be essential reading for all clinicians and other professionals dealing with addiction, from counsellors and social workers to policy makers.
Estimates indicate that as many as 1 in 4 Americans will experience a mental health problem or will misuse alcohol or drugs in their lifetimes. These disorders are among the most highly stigmatized health conditions in the United States, and they remain barriers to full participation in society in areas as basic as education, housing, and employment. Improving the lives of people with mental health and substance abuse disorders has been a priority in the United States for more than 50 years. The Community Mental Health Act of 1963 is considered a major turning point in America's efforts to improve behavioral healthcare. It ushered in an era of optimism and hope and laid the groundwork for the consumer movement and new models of recovery. The consumer movement gave voice to people with mental and substance use disorders and brought their perspectives and experience into national discussions about mental health. However over the same 50-year period, positive change in American public attitudes and beliefs about mental and substance use disorders has lagged behind these advances. Stigma is a complex social phenomenon based on a relationship between an attribute and a stereotype that assigns undesirable labels, qualities, and behaviors to a person with that attribute. Labeled individuals are then socially devalued, which leads to inequality and discrimination. This report contributes to national efforts to understand and change attitudes, beliefs and behaviors that can lead to stigma and discrimination. Changing stigma in a lasting way will require coordinated efforts, which are based on the best possible evidence, supported at the national level with multiyear funding, and planned and implemented by an effective coalition of representative stakeholders. Ending Discrimination Against People with Mental and Substance Use Disorders: The Evidence for Stigma Change explores stigma and discrimination faced by individuals with mental or substance use disorders and recommends effective strategies for reducing stigma and encouraging people to seek treatment and other supportive services. It offers a set of conclusions and recommendations about successful stigma change strategies and the research needed to inform and evaluate these efforts in the United States.
The World Drug Report provides an annual overview of recent developments for various drug categories. Chapter one of the World Drug Report 2015 provides a global overview of the latest developments with respect to opiates, cocaine, cannabis and synthetic drugs, ranging from production to trafficking as well as consumption and the health impact of drug use. Chapter two focuses on Alternative Development, its relation to illicit cultivation, and also within the broader context of the development agenda.
Illicit drug supply and demand are inextricably linked components of a single phenomenon. Contents of this 2007 report by the International Narcotics Control Board: (I) The Principle of Proportionality and Drug-Related Offenses; (II) Operation of the International Drug Control System; (III) Analysis of the World Situation; (IV) Recommendations to Governments, the United Nations and Other Relevant and Regional Organizations. Annexes: (I) Regional Groupings Used in the Report of the International Narcotics Control Board; (II) Current Membership of the International Narcotics Control Board.
This timely and important work offers an in-depth analysis of the existence—or nonexistence—of a nexus between international terrorism and drug trafficking emanating from Afghanistan. The Nexus: International Terrorism and Drug Trafficking from Afghanistan addresses an issue that directly impacts the prospects for resolution of the current insurgency in that nation. Written by noted terrorism expert Frank Shanty, the book explores the nature and the extent of involvement between international criminal drug traffickers, particularly of drugs originating from Afghanistan, and international terrorist networks with global reach. Shanty dispels the myths and disinformation surrounding this vital—and controversial—question, even as he arrives at his own answers. In addition to offering a historical overview of the opium problem in Afghanistan from the late 1970s to 2010, the book looks at three distinct phenomena. It examines the existence, characteristics, and behavior of international terrorists operating from Afghanistan, specifically the evolution and ascendancy of al-Qaeda and the Taliban and the nature of their relationship. It looks at Afghanistan's opium trade relative to specific-actor involvement and, finally, it analyzes allegations of a link between terrorists in Afghanistan and international drug criminals and the implications of that connection.
The Politics of Narcotic Drugs brings together leading experts on the drugs trade to provide an accessible yet detailed analysis of the multiple challenges that the contemporary trade in narcotic drugs and its prohibition pose, from the local to the international community. Through the use of country and regional case studies that include Afghanistan, Mexico, Colombia and the Middle East, the drivers of the drugs trade and the security and development dilemmas created by the prohibition of narcotic substances are explored. Contributions that assess the international drug control regime, British anti-drug enforcement organizations, 'narcoterrorism' and options for drug policy reform engage readers in current debates and the narrative frameworks that shape discussion of the drugs issue. The book is an invaluable guide to the dynamic and far-reaching issue of narcotic drugs and the impact of their prohibition on our countries and communities. The chapters are followed by an A-Z glossary of key terms, issues and organizations, and a section of maps and statistics.
